Literature DB >> 22760763

Statin and aspirin therapy for the prevention of cardiovascular events in patients with type 2 diabetes mellitus.

Jacob A Udell1, Benjamin M Scirica, Eugene Braunwald, Itamar Raz, Ph Gabriel Steg, Jaime Davidson, Boaz Hirshberg, Deepak L Bhatt.   

Abstract

Patients with type 2 diabetes mellitus are at 2 to 4 times increased risk of cardiovascular events compared with those without diabetes, both among patients with multiple risk factors only and those with established atherothrombosis. In this review, we provide recommendations for the use of statins and aspirin for the prevention of cardiovascular events in high-risk patients with diabetes mellitus.
© 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22760763      PMCID: PMC6652724          DOI: 10.1002/clc.22032

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  4 in total

1.  Predictors of Peak Troponin Level in Acute Coronary Syndromes: Prior Aspirin Use and SYNTAX Score.

Authors:  Hemal A Bhatt; Dharmesh R Sanghani; David Lee; Kell N Julliard; George A Fernaine
Journal:  Int J Angiol       Date:  2015-03-23

2.  Perception of diabetes management and cardiovascular disease risk among men with type 2 diabetes: A qualitative study.

Authors:  Manar M Nabolsi
Journal:  Nurs Open       Date:  2020-02-12

3.  Overexpression of microRNA-216a-3p Accelerates the Inflammatory Response in Cardiomyocytes in Type 2 Diabetes Mellitus by Targeting IFN-α2.

Authors:  Xiaomeng Liu; Yusong Zhang; Hongwei Liang; Yanchao Xu
Journal:  Front Endocrinol (Lausanne)       Date:  2020-11-27       Impact factor: 5.555

4.  Acupuncture treatment for carotid atherosclerotic plaques: study protocol for a pilot randomized, single blinded, controlled clinical trial.

Authors:  Junhe Zhou; Lin Zhao; Lingcui Meng; Huitao Liang; Ting Zhou; Siting Ye; Zhiqi Qi; Xichang Huang; Peng Zhou; Wenbin Fu
Journal:  Trials       Date:  2020-09-07       Impact factor: 2.279

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.